Clinical Trials in New York

Showing 16541-16560 of 22,668 trials

Asthma Mobile Health Application 2.0

NCT03248869

Mobile health applications (MHA) are increasingly being explored as tools to assist in management of chronic diseases. Little is known regarding which characteristics of MHAs are effective and there is limited data suggesting a real-world impact on health outcomes. Asthma is one of the most common and costly of the chronic diseases, impacting a broad range of the population including both children and adults. It is a variable disease necessitating regular medication use, monitoring of symptoms, and avoidance of specific triggers. These characteristics of asthma make it a chronic disease that is particularly amenable to having an MHA facilitate active monitoring outside of periodic traditional medical visits. The study team has designed a MHA focused on asthma subjects to test the feasibility of an asthma mobile health application (AMHA). The AMHA 2.0 study is the result of a collaboration between MHA developers and Mount Sinai faculty with expertise in the fields of asthma, research design, data storage, and data analysis. AMHA 2.0 incorporated elements of usual clinical care (that may take place during typical office visits), such as medication reminders, a daily asthma diary to track asthma control (AC) and medication use, patient education and assessments of quality of life (QoL), and health care utilization (HCU).

Asthma

Icahn School of Medicine at Mount Sinai7,752 participantsStarted Mar 2015

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

NCT00325728

The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbance

Chronic Insomnia

Takeda74 participantsStarted Mar 2006

Alabaster, Alabama, United States • Huntsville, Alabama, United States • Phoenix, Arizona, United States +69 more locations

Asthma Mobile Health Application 2.0

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Find Trials by Condition in New York

D-serine for the Schizophrenia Prodrome

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Everolimus Post Orthotopic Liver Transplant

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Safety and Adherence of a Non-medicated Intravaginal Ring (IVR)

Cyclic Versus Daily Teriparatide on Bone Mass

Safety Study to Evaluate FluMist in Immunocompromised Children

Multicenter Prospective Trial on Hemorrhoids

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors